Table 2.
Contingency tables of the individuals classified according to the Adpn/Lep ratio and metabolic conditions.
| ≥1.0 | ≥0.5 <1.0 | <0.5 | p | |
|---|---|---|---|---|
| Obesity (n = 292) | <0.001 | |||
| Lean | 50 (60%) | 29 (35%) | 4 (5%) | |
| Obese | 1 (1%) | 21 (10%) | 187 (89%) | |
| Type 2 diabetes (n = 289) | <0.001 | |||
| Normoglycemia | 40 (25%) | 33 (21%) | 84 (54%) | |
| Impaired fasting glucose | 10 (10%) | 13 (14%) | 72 (76%) | |
| Type 2 diabetes | 1 (3%) | 4 (11%) | 32 (86%) | |
| Metabolic syndrome (n = 246) | <0.001 | |||
| Without MS | 32 (27%) | 31 (26%) | 57 (47%) | |
| With MS | 1 (1%) | 11 (9%) | 114 (90%) |
Data presented as number of subjects. Individuals were segregated according to the Adpn/Lep ratio proposed cut-offs: ≥1.0, ≥0.5 <1.0 and <0.5. Differences in distribution regarding the proposed cut-offs and each metabolic condition (obesity, type 2 diabetes or metabolic syndrome) were analyzed by χ2 analysis. Partial percentages within groups are shown. MS, metabolic syndrome.